Relationship of -31G/C (rs9904341) polymorphism in the survivin gene BIRC5 and the risk of bladder cancer
Open Access
- 3 September 2022
- journal article
- research article
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 21 (4) , 64-71
Abstract
Purpose: To study the relationship between the -31G/C (rs9904341) polymorphism in the promoter region of the survivin protein gene and the predisposition to bladder cancer (BC) in patients of the Krasnoyarsk region. Material and methods. The allelic composition of the studied gene was determined in a group of 158 BC patients, consisting of 30 women and 128 men (mean age 65.6 ± 10.7, median: 66.5; C25–C75: 59–72). The control group included 117 healthy donors and consisted of 27 women and 90 men with an average age of 60.2 ± 5.1 (median: 60; C25–C75: 57–63.25). The allelic composition was determined using the bioluminescent method. A sample with the GC genotype confirmed by sanger sequencing (center for collective use “genomika”, Novosibirsk, Russia) was used as a control. The Mann–Whitney U test was used to compare quantitative data. the studied sample was in Hardy–Weinberg equilibrium (p>0.5). The pearson χ2 test was used to compare the frequencies of gene variants among BC cases and control samples. The association between variants rs9904341 and BC was assessed in terms of odds ratio (OR) with a 95 % confidence interval (CI); p valuesResults. The allelic composition was determined for the genes of patients and control group participants: GG – 62 (39.2%) vs 43 (36.8%); GC – 82 (51.9%) vs 54 (46.2%); CC – 14 (8.9%) vs 20 (17.15%). The relationship between the presence of the C allele and BC was assessed using the recessive inheritance model, combining all carriers – heterozygotes and homozygotes. The frequency of occurrence of genotypes for patients and the control group was established: GG + GC – 144 (91.1%) vs 97 (82.9%); CC – 14 (8.9%) vs 20 (17.1%). Thus, carriers of the CС genotype were significantly less in patients: OR (95% CI) 0.47 (0.23–0.98), p=0.04. The relationship with tumor invasion was not significant (p=0.08). Conclusion. Based on the results of detecting the rs9904341 (G/C) polymorphism among BC patients of the Krasnoyarsk region, a protective effect of the carriage of the CC genotype was found. In order to study the allelic composition with the threat of recurrence of the disease, additional research is needed.Keywords
This publication has 24 references indexed in Scilit:
- Association of survivin splice variants with prognosis and treatment of breast cancerWorld Journal of Clinical Oncology, 2014
- Obelin mutants as reporters in bioluminescent dual-analyte binding assayAnalytical Methods, 2012
- Survivin gene promoter polymorphism ‐31G/C as a risk factor for keratocystic odontogenic tumor developmentEuropean Journal of Oral Sciences, 2012
- Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohortMolecular Biology Reports, 2011
- Survivin promoter −31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysisMolecular Biology Reports, 2011
- Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibilityInternational Journal of Cancer, 2010
- The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall SurvivalAnalytical Cellular Pathology, 2010
- Gene Expression of Survivin and Its Spliced Isoforms Associated With Proliferation and Aggressive Phenotypes of Prostate CancerUrology, 2008
- Polymorphisms in the survivin gene and the risk of lung cancerLung Cancer, 2008
- A Mutation Found in the Promoter Region of the Human Survivin Gene Is Correlated to Overexpression of Survivin in Cancer CellsDNA and Cell Biology, 2004